Wells Fargo downgraded Omega Healthcare (OHI) to Equal Weight from Overweight with a price target of $45, down from $48. The firm views the stock’s valuation as full at current levels. Genesis is 4.6% of Omega’s annualized rent and filed for Chapter 11 in July of 2025 to address malpractice claims, the analyst tells investors in a research note. Wells says Genesis’ new buyer, 101 West, is not expected to take on Omega’s $125M term loan at 13.2%. It believes the company’s dispositions could be elevated this year. Wells sees risk to Street net investment expectations as Omega’s yields compress.
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on OHI:
- Omega Healthcare downgraded to Equal Weight from Overweight at Wells Fargo
- Omega Healthcare initiated with a Buy at Goldman Sachs
- Omega Healthcare downgraded to Market Perform from Outperform at BMO Capital
- Omega Healthcare price target raised to $51 from $50 at UBS
- Omega Healthcare Amends Executive Contracts, Enhances Severance Terms